NCT01447914 2019-08-28Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple MyelomaNational Cancer Institute (NCI)Phase 2 Completed16 enrolled 11 charts
NCT01002755 2019-05-07Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaM.D. Anderson Cancer CenterPhase 2 Completed36 enrolled 7 charts